Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 2
2004 6
2005 8
2006 3
2007 7
2008 7
2010 9
2011 8
2012 10
2013 9
2014 15
2015 12
2016 23
2017 31
2018 16
2019 26
2020 21
Text availability
Article attribute
Article type
Publication date

Search Results

191 results
Results by year
Filters applied: . Clear all
Page 1
Did you mean liqun wang (274 results)?
Inducing and exploiting vulnerabilities for the treatment of liver cancer.
Wang C, Vegna S, Jin H, Benedict B, Lieftink C, Ramirez C, de Oliveira RL, Morris B, Gadiot J, Wang W, du Chatinier A, Wang L, Gao D, Evers B, Jin G, Xue Z, Schepers A, Jochems F, Sanchez AM, Mainardi S, Te Riele H, Beijersbergen RL, Qin W, Akkari L, Bernards R. Wang C, et al. Among authors: wang l. Nature. 2019 Oct;574(7777):268-272. doi: 10.1038/s41586-019-1607-3. Epub 2019 Oct 2. Nature. 2019. PMID: 31578521 Free PMC article.
An Acquired Vulnerability of Drug-Resistant Melanoma with Therapeutic Potential.
Wang L, Leite de Oliveira R, Huijberts S, Bosdriesz E, Pencheva N, Brunen D, Bosma A, Song JY, Zevenhoven J, Los-de Vries GT, Horlings H, Nuijen B, Beijnen JH, Schellens JHM, Bernards R. Wang L, et al. Cell. 2018 May 31;173(6):1413-1425.e14. doi: 10.1016/j.cell.2018.04.012. Epub 2018 May 10. Cell. 2018. PMID: 29754815 Free article.
Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma.
Sun C, Wang L, Huang S, Heynen GJ, Prahallad A, Robert C, Haanen J, Blank C, Wesseling J, Willems SM, Zecchin D, Hobor S, Bajpe PK, Lieftink C, Mateus C, Vagner S, Grernrum W, Hofland I, Schlicker A, Wessels LF, Beijersbergen RL, Bardelli A, Di Nicolantonio F, Eggermont AM, Bernards R. Sun C, et al. Among authors: wang l. Nature. 2014 Apr 3;508(7494):118-22. doi: 10.1038/nature13121. Epub 2014 Mar 26. Nature. 2014. PMID: 24670642 Free article.
Regulatory Mechanisms of the NLRP3 Inflammasome, a Novel Immune-Inflammatory Marker in Cardiovascular Diseases.
An N, Gao Y, Si Z, Zhang H, Wang L, Tian C, Yuan M, Yang X, Li X, Shang H, Xiong X, Xing Y. An N, et al. Among authors: wang l. Front Immunol. 2019 Jul 10;10:1592. doi: 10.3389/fimmu.2019.01592. eCollection 2019. Front Immunol. 2019. PMID: 31354731 Free PMC article. Review.
Roles of Inflammasomes in Inflammatory Kidney Diseases.
Fan J, Xie K, Wang L, Zheng N, Yu X. Fan J, et al. Among authors: wang l. Mediators Inflamm. 2019 Jul 21;2019:2923072. doi: 10.1155/2019/2923072. eCollection 2019. Mediators Inflamm. 2019. PMID: 31427885 Free PMC article. Review.
A CRISPR screen identifies CDK7 as a therapeutic target in hepatocellular carcinoma.
Wang C, Jin H, Gao D, Wang L, Evers B, Xue Z, Jin G, Lieftink C, Beijersbergen RL, Qin W, Bernards R. Wang C, et al. Among authors: wang l. Cell Res. 2018 Jun;28(6):690-692. doi: 10.1038/s41422-018-0020-z. Epub 2018 Mar 5. Cell Res. 2018. PMID: 29507396 Free PMC article. No abstract available.
High-Throughput Functional Genetic and Compound Screens Identify Targets for Senescence Induction in Cancer.
Wang L, Leite de Oliveira R, Wang C, Fernandes Neto JM, Mainardi S, Evers B, Lieftink C, Morris B, Jochems F, Willemsen L, Beijersbergen RL, Bernards R. Wang L, et al. Cell Rep. 2017 Oct 17;21(3):773-783. doi: 10.1016/j.celrep.2017.09.085. Cell Rep. 2017. PMID: 29045843 Free article.
Phospho-ERK is a biomarker of response to a synthetic lethal drug combination of sorafenib and MEK inhibition in liver cancer.
Wang C, Jin H, Gao D, Lieftink C, Evers B, Jin G, Xue Z, Wang L, Beijersbergen RL, Qin W, Bernards R. Wang C, et al. Among authors: wang l. J Hepatol. 2018 Nov;69(5):1057-1065. doi: 10.1016/j.jhep.2018.07.004. Epub 2018 Jul 18. J Hepatol. 2018. PMID: 30030148
Repurposing of clinically approved drugs for treatment of coronavirus disease 2019 in a 2019-novel coronavirus-related coronavirus model.
Fan HH, Wang LQ, Liu WL, An XP, Liu ZD, He XQ, Song LH, Tong YG. Fan HH, et al. Chin Med J (Engl). 2020 May 5;133(9):1051-1056. doi: 10.1097/CM9.0000000000000797. Chin Med J (Engl). 2020. PMID: 32149769 Free PMC article.
Development and Validation of a Deep Learning Algorithm for Mortality Prediction in Selecting Patients With Dementia for Earlier Palliative Care Interventions.
Wang L, Sha L, Lakin JR, Bynum J, Bates DW, Hong P, Zhou L. Wang L, et al. JAMA Netw Open. 2019 Jul 3;2(7):e196972. doi: 10.1001/jamanetworkopen.2019.6972. JAMA Netw Open. 2019. PMID: 31298717 Free PMC article.
191 results
Jump to page
Feedback